Návratnosť imania spoločnosti Illumina
Aká je hodnota metriky Návratnosť imania spoločnosti Illumina?
Hodnota metriky Návratnosť imania spoločnosti Illumina, Inc. je -42.80%
Aká je definícia metriky Návratnosť imania?
Návratnosť imania (Return on equity - ROE) je rentabilita vlastného imania. Vypočíta sa vydelením čistého príjmu za fiškálny rok vlastným imaním.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Návratnosť imania spoločností v sektore Miscellaneous sektor na LSE v porovnaní so spoločnosťou Illumina
Čomu sa venuje spoločnosť Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Firmy s metrikou návratnosť imania podobnou spoločnosti Illumina
- Hodnota metriky Návratnosť imania spoločnosti Bossini International je -42.92%
- Hodnota metriky Návratnosť imania spoločnosti Bharat Road Network je -42.90%
- Hodnota metriky Návratnosť imania spoločnosti Arcus Biosciences Inc je -42.86%
- Hodnota metriky Návratnosť imania spoločnosti Monarch Mining je -42.83%
- Hodnota metriky Návratnosť imania spoločnosti Shandong Molong Petroleum Machinery je -42.82%
- Hodnota metriky Návratnosť imania spoločnosti Galiano Gold je -42.81%
- Hodnota metriky Návratnosť imania spoločnosti Illumina je -42.80%
- Hodnota metriky Návratnosť imania spoločnosti Hi-Level Technology je -42.80%
- Hodnota metriky Návratnosť imania spoločnosti Vimy Resources je -42.78%
- Hodnota metriky Návratnosť imania spoločnosti Vimy Resources je -42.78%
- Hodnota metriky Návratnosť imania spoločnosti Altan Rio Minerals je -42.76%
- Hodnota metriky Návratnosť imania spoločnosti U.S. Gold Corp je -42.73%
- Hodnota metriky Návratnosť imania spoločnosti E Automotive Inc je -42.72%